Keywords: pharmascience, market, synsorb, pk, canada, distribute, biotech

Pharmascience To Market Synsorb Pk

Article | 20 January 1997

Pharmascience of Canada will market and distribute Synsorb Biotech'spotential treatment for the prevention of hemolytic uremic syndrome, Synsorb Pk.

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in